women's health
Nanopath Nabs $3M SBIR Grant for Pelvic, Gynecologic Infection Tests
The National Institutes of Health funding and $1 million awarded in September from the National Science Foundation will support the firm's R&D.
Craig-Hallum Initiates Coverage of Natera With Buy Rating
Analyst Bill Bonello noted growth potential across Natera's markets, along with potential risks related to reimbursement, competition, and profitability.
Natera pointed to expanded Signatera coverage, the upcoming completion of its ALTAIR study, and potential uplift from recent biomarker legislation as future growth drivers.
The firm has updated its low-cost Hub instrument and pivoted its testing menu toward multiplex point-of-care panels.
Natera Acquires Reproductive Health Assets From Invitae for up to $52.5M
As part of the transaction, Invitae will begin transitioning its noninvasive prenatal screening and carrier screening customers to Natera.